Mental Health screening in cystic fibrosis centres across Europe

Autor: Abbott, J., Havermans, T., Jarvholm, S., Landau, E., Prins, Y., Smrekar, U., Staab, D., Verity, L., Verkleij, M.

Publikováno v: In Journal of Cystic Fibrosis March 2019 18(2):299-303

The cost-effectiveness of different visual acuity screening strategies in three European countries: a microsimulation study

Autor: Heijnsdijk, E. A. M., Verkleij, M. L., Carlton, J., Horwood, Anna M., Fronius, M., Kik, J., Sloot, F., Vladutiu, C., Simonsz, H. J., de Koning, H. J., The EUSCREEN Foundation

Childhood vision screening programmes in Europe differ by age, frequency and location at which the child is screened, and by the professional who performs the test. The aim of this study is to compare the cost-effectiveness for three countries with d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a7e0037c814c2c955c95dd81d245a63b
https://centaur.reading.ac.uk/105937/3/1-s2.0-S2211335522001759-main.pdf

Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients

Autor: Neerincx, Anne H., Whiteson, Katrine, Phan, Joann L., Brinkman, Paul, Abdel-Aziz, Mahmoud I., Weersink, Els J.M., Altenburg, Josje, Majoor, Christof J., Maitland-van der Zee, Anke H., Bos, Lieuwe D.J., Haarman, E., Rutjes, N. W., Terheggen-Lagro, S. W.J., Seljogi, D., Kemper, E. M., Lutter, R., Vijverberg, S. J., Vonk, S. E.M., Adriaens, N., Lub, R., van Brederode, M., van der Schaaf, L., Verkleij, M., van Gilst, N. A., Hofsteenge, G. H., Brackel, C. L.H., Lakeman, P., Bon, I. C.M., Tanner, S. P.M., Sterk, P. J., Longo, C., Sinha, A., Fenn, D., Lammers, A., Richards, L. B., van Bragt, J. M., Kos, R., Dagelet, J. W.F., Lone-Latif, S. J.A., Schultz, M. J., Smit, M. R., Hagens, L. A.

Publikováno v: Neerincx, A H, Whiteson, K, Phan, J L, Brinkman, P, Abdel-Aziz, M I, Weersink, E J M, Altenburg, J, Majoor, C J, Maitland-van der Zee, A H, Bos, L D J, Haarman, E, Rutjes, N W, Terheggen-Lagro, S W J, Seljogi, D, Kemper, E M, Lutter, R, Vijverberg, S J, Vonk, S E M, Adriaens, N, Lub, R, van Brederode, M, van der Schaaf, L, Verkleij, M, van Gilst, N A, Hofsteenge, G H, Brackel, C L H, Lakeman, P, Bon, I C M, Tanner, S P M, Sterk, P J, Longo, C, Sinha, A, Fenn, D, Lammers, A, Richards, L B, van Bragt, J M, Kos, R, Dagelet, J W F, Lone-Latif, S J A, Schultz, M J, Smit, M R, Hagens, L A, Amsterdam mucociliary clearance disease research group & Amsterdam UMC Breath Research Group 2021, ' Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients ', ERJ Open Research, vol. 7, no. 2, 00731-2020 . https://doi.org/10.1183/23120541.00731-2020
ERJ Open Research, 7(2):00731-2020. BMJ Publishing Group
ERJ Open Research
article-version (VoR) Version of Record
ERJ open research, 7(2):00731-2020. European Respiratory Society
ERJ Open Research, Vol 7, Iss 2 (2021)

Rationale Targeted cystic fibrosis (CF) therapy with lumacaftor/ivacaftor partly restores chloride channel function and improves epithelial fluid transport in the airways. Consequently, changes may occur in the microbiome, which is adapted to CF lung

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab579d0ee582c686532e1520e3205a9
https://research.vumc.nl/en/publications/cdb44a8a-7c3d-44d5-8941-b1e909993ffb

WS11.03 Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: healthcare providers’ observations across US Centres

Autor: Quittner, A., Muther, E., Georgiopoulos, A., Smith, B., Tillman, L., Graziano, S., Verkleij, M., Lomas, P., Bathgate, C.

Publikováno v: In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S22-S22

P386 The Dutch Gastrointestinal Symptom Tracker for People with Cystic Fibrosis: associations with anxiety, depression and health-related quality of life.

Autor: Verkleij, M.^1,2,3 (AUTHOR), Vlieg-Boerstra, B.^4,5 (AUTHOR), Hofsteenge, G.H.⁶ (AUTHOR), Twisk, J.⁷ (AUTHOR), Quittner, A.⁸ (AUTHOR), de Meij, T.⁹ (AUTHOR)

Publikováno v: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS186-S186. 1p.